Concomitant or Sequential Therapy as the First-line Therapy for Eradication of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis | Zendy

Hyun Jin Bae | Zendy; Joon Sung Kim | Zendy; ByungWook Kim | Zendy; Yun Jung Nam | Zendy

Open Access

Concomitant or Sequential Therapy as the First-line Therapy for Eradication of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis

Author(s) -

Hyun Jin Bae,

Joon Sung Kim,

ByungWook Kim,

Yun Jung Nam

Publication year - 2018

Publication title -

korean journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.203

H-Index - 25

eISSN - 2233-6869

pISSN - 1598-9992

DOI - 10.4166/kjg.2018.71.1.31

Subject(s) - helicobacter pylori , medicine , regimen , concomitant , odds ratio , clarithromycin , confidence interval , meta analysis , adverse effect , intention to treat analysis , gastroenterology

In Korea, increasing clarithromycin resistance has led to the need for an alternative first-line therapy for the eradication of Helicobacter pylori ( H. pylori ) infection. Concomitant therapy (CT) and sequential therapy (ST) have been proposed as alternative regimens. The aim of this study was to compare the eradication rate from using CT and ST in Korea.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research